Sex-related Factors in Autoimmune Liver Diseases

Overview

Journal Semin Immunopathol

Publisher Springer

Specialties Allergy & Immunology
Pathology

Date 2018 Oct 3

PMID 30276446

Citations 21

Authors

Dorothee Schwinge

Christoph Schramm

Affiliations

Soon will be listed here.

Abstract

Autoimmune diseases are a broad range of diseases in which the immune system produces an inappropriate response to self-antigens. This results in inflammation, damage, or dysfunction of tissues and/or organs. Many autoimmune diseases are more common in women and differences between female and male immune and autoimmune responses have been well documented. In general, most of the autoimmune diseases seem to affect more females, although there are exceptions. Autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC) are considered to be autoimmune liver diseases (AILD). They all are rare diseases and they result in significant morbidity and mortality. The female predominance in PBC and AIH are among the strongest among autoimmune diseases. However, the mechanisms responsible for the sex differences in autoimmune liver diseases are largely unknown. In this review, we discuss the recent findings on the influence of sex-dependent mechanisms, which may contribute to differences in presentation, clinical characteristics, disease course, and complications observed between female and male patients with autoimmune liver disease.

Citing Articles

New horizons of human genetics in digestive diseases.

Chen L, Lv G eGastroenterology. 2025; 1(2):e100029.

PMID: 39943996 PMC: 11770434. DOI: 10.1136/egastro-2023-100029.

Hellenic Association for the Study of the Liver (HASL): revised clinical practice guidelines for autoimmune hepatitis.

Dalekos G, Papatheodoridis G, Koskinas J, Goulis I, Rigopoulou E, Tiniakos D Ann Gastroenterol. 2024; 37(6):623-654.

PMID: 39568707 PMC: 11574148. DOI: 10.20524/aog.2024.0924.

Epidemiology of liver diseases: global disease burden and forecasted research trends.

Xiao J, Wang F, Yuan Y, Gao J, Xiao L, Yan C Sci China Life Sci. 2024; 68(2):541-557.

PMID: 39425834 DOI: 10.1007/s11427-024-2722-2.

Neuroimmune modulation in liver pathophysiology.

Zou J, Li J, Wang X, Tang D, Chen R J Neuroinflammation. 2024; 21(1):188.

PMID: 39090741 PMC: 11295927. DOI: 10.1186/s12974-024-03181-w.

Progress in the Management of Patients with Cholestatic Liver Disease: Where Are We and Where Are We Going?.

Luo X, Lu L J Clin Transl Hepatol. 2024; 12(6):581-588.

PMID: 38974958 PMC: 11224908. DOI: 10.14218/JCTH.2023.00519.

References

Lleo A, Zhang W, Zhao M, Tan Y, Bernuzzi F, Zhu B . DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis. Clin Epigenetics. 2015; 7:61. PMC: 4491885. DOI: 10.1186/s13148-015-0098-9. View

Sabino J, Vieira-Silva S, Machiels K, Joossens M, Falony G, Ballet V . Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut. 2016; 65(10):1681-9. PMC: 5036217. DOI: 10.1136/gutjnl-2015-311004. View

Carbone M, Bonato G, Invernizzi P . Female preponderance of primary biliary cholangitis is all about our understanding of its autoimmune nature. Hepatology. 2017; 67(4):1210-1212. DOI: 10.1002/hep.29625. View

Chang J, Go S, Verhoeven A, Beuers U, Oude Elferink R . Role of the bicarbonate-responsive soluble adenylyl cyclase in cholangiocyte apoptosis in primary biliary cholangitis; a new hypothesis. Biochim Biophys Acta Mol Basis Dis. 2017; 1864(4 Pt B):1232-1239. DOI: 10.1016/j.bbadis.2017.09.022. View

Karlsen T, Folseraas T, Thorburn D, Vesterhus M . Primary sclerosing cholangitis - a comprehensive review. J Hepatol. 2017; 67(6):1298-1323. DOI: 10.1016/j.jhep.2017.07.022. View

Kevans D, Tyler A, Holm K, Jorgensen K, Vatn M, Karlsen T . Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis. J Crohns Colitis. 2015; 10(3):330-7. PMC: 4957469. DOI: 10.1093/ecco-jcc/jjv204. View

Czaja A . Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis. Clin Gastroenterol Hepatol. 2008; 6(4):379-88. DOI: 10.1016/j.cgh.2007.12.048. View

Alvaro D, Onori P, Metalli V, Svegliati-Baroni G, Folli F, Franchitto A . Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology. 2002; 36(2):297-304. DOI: 10.1053/jhep.2002.34741. View

Boonstra K, Beuers U, Ponsioen C . Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012; 56(5):1181-1188. DOI: 10.1016/j.jhep.2011.10.025. View

10.

Feld J, Dinh H, Arenovich T, Marcus V, Wanless I, Heathcote E . Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology. 2005; 42(1):53-62. DOI: 10.1002/hep.20732. View

11.

Schramm C, Herkel J, Beuers U, Kanzler S, Galle P, Lohse A . Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol. 2006; 101(3):556-60. DOI: 10.1111/j.1572-0241.2006.00479.x. View

12.

Hirschfield G, Karlsen T, Lindor K, Adams D . Primary sclerosing cholangitis. Lancet. 2013; 382(9904):1587-99. DOI: 10.1016/S0140-6736(13)60096-3. View

13.

Brix T, Knudsen G, Kristiansen M, Kyvik K, Orstavik K, Hegedus L . High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metab. 2005; 90(11):5949-53. DOI: 10.1210/jc.2005-1366. View

14.

Vergani D, Longhi M, Bogdanos D, Ma Y, Mieli-Vergani G . Autoimmune hepatitis. Semin Immunopathol. 2009; 31(3):421-35. DOI: 10.1007/s00281-009-0170-7. View

15.

Kyewski B, Derbinski J . Self-representation in the thymus: an extended view. Nat Rev Immunol. 2004; 4(9):688-98. DOI: 10.1038/nri1436. View

16.

Lohse A, Mieli-Vergani G . Autoimmune hepatitis. J Hepatol. 2010; 55(1):171-82. DOI: 10.1016/j.jhep.2010.12.012. View

17.

Trivedi P, Adams D . Mucosal immunity in liver autoimmunity: a comprehensive review. J Autoimmun. 2013; 46:97-111. DOI: 10.1016/j.jaut.2013.06.013. View

18.

Chandok N, Hirschfield G . Management of primary sclerosing cholangitis: conventions and controversies. Can J Gastroenterol. 2012; 26(5):261-8. PMC: 3352841. DOI: 10.1155/2012/426430. View

19.

Ruhlemann M, Heinsen F, Zenouzi R, Lieb W, Franke A, Schramm C . Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis. Gut. 2016; 66(4):753-754. DOI: 10.1136/gutjnl-2016-312180. View

20.

Al-Chalabi T, Boccato S, Portmann B, McFarlane I, Heneghan M . Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol. 2006; 45(4):575-83. DOI: 10.1016/j.jhep.2006.04.007. View